Sensus Healthcare and Megatop MTC are pleased to announce the SFDA approval of the SRT-100™ advanced superficial radiotherapy platform to be sold in China. This approval allows Megatop MTC to...

Sensus Healthcare, the global leader in superficial radiotherapy for non-melanoma skin cancers, announces the purchase of their SRT-100™ therapy system by Hong Kong Sanatorium & Hospital of Hong...

Sensus Healthcare, a global leader in superficial radiotherapy for non-melanoma skin cancers, is joining forces with Mission Search Corporation, a Tampa, Florida based healthcare search and...

Sensus Healthcare and Texas Dermatology Associates at Baylor University Medical Center of Dallas, TX are proud to announce the establishment of the SRT University™ Comprehensive Education Series...

Sensus Healthcare is pleased to announce that the Prince of Wales Hospital in Hong Kong has become the first healthcare facility in the country to purchase and deploy an SRT-100™ non-invasive...